Clinical trialNCT06510582RecruitingPhase 1/PHASE2Interventional

Chronic Subdural Hematoma Treatment With Intra-Arterial Bevacizumab Injection

SponsorThe Cooper Health SystemEnrollment140Chronic Subdural Hematoma

View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The goal of this clinical trial is to test whether infusing bevacizumab into the middle meningeal arteries can be used to treat chronic subdural hematomas (cSDH). The main questions it aims to answer are: * Is bevacizumab infusion safe in cSDH patients? * Is bevacizumab infusion effective in treating cSDH?

clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

Ajith J Thomas, MD
The Cooper Health System
Study Chair
clinicaltrials.gov ↗
Jane Khalife, MD
The Cooper Health System
Principal Investigator
clinicaltrials.gov ↗
Manisha Koneru, MD
The Cooper Health System
Study Chair
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

Cooper University Health Care
Camden, New Jersey, United States
Jane Khalife, MD
Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Bevacizumab →

Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 17 Jun 2024
Primary completion: 30 Jun 2028
Completion: 30 Jun 2028
Last update posted: 1 Jul 2025
Registered enrollment: 140
Registry id: NCT06510582

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.